224 related articles for article (PubMed ID: 32120283)
1. Doxorubicin, paclitaxel, and cisplatin based chemotherapy for the treatment of angiosarcoma: Two case reports.
Lewcun JA; Pameijer C; Kass R; Cream L; Hershock D; Brooks AJ; Dodge DG
Int J Surg Case Rep; 2020; 68():83-87. PubMed ID: 32120283
[TBL] [Abstract][Full Text] [Related]
2. Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report.
Suzuki Y; Taniguchi K; Hatono M; Kajiwara Y; Abe Y; Kawada K; Tsukioki T; Kochi M; Nishiyama K; Iwamoto T; Ikeda H; Shien T; Taira N; Tabata M; Yanai H; Doihara H
Surg Case Rep; 2020 Jan; 6(1):25. PubMed ID: 31950295
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide combined with neoadjuvant chemotherapy in angiosarcoma of the breast with complete pathologic response: case report and review of literature.
Alvarado-Miranda A; Bacon-Fonseca L; Ulises Lara-Medina F; Maldonado-Martínez H; Arce-Salinas C
Breast Care (Basel); 2013 Mar; 8(1):74-6. PubMed ID: 24715848
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
6. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Loibl S; O'Shaughnessy J; Untch M; Sikov WM; Rugo HS; McKee MD; Huober J; Golshan M; von Minckwitz G; Maag D; Sullivan D; Wolmark N; McIntyre K; Ponce Lorenzo JJ; Metzger Filho O; Rastogi P; Symmans WF; Liu X; Geyer CE
Lancet Oncol; 2018 Apr; 19(4):497-509. PubMed ID: 29501363
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Systemic Treatment of Primary Angiosarcoma.
Heinhuis KM; IJzerman NS; van der Graaf WTA; Kerst JM; Schrage Y; Beijnen JH; Steeghs N; van Houdt WJ
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806524
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel.
Wei H; Mao J; Wu Y; Zhou Q
Front Oncol; 2021; 11():791121. PubMed ID: 34976833
[TBL] [Abstract][Full Text] [Related]
11. A systematic overview of chemotherapy effects in ovarian cancer.
Högberg T; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
[TBL] [Abstract][Full Text] [Related]
12. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
13. Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study.
Frasci G; Comella P; D'Aiuto G; Budillon A; Barbarulo D; Thomas R; Capasso I; Casaretti R; Daponte A; Caponigro F; Gravina A; Maiorino L; Caratení G; Gentile A; Comella G
Breast Cancer Res Treat; 1998 May; 49(1):13-26. PubMed ID: 9694607
[TBL] [Abstract][Full Text] [Related]
14. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.
Fury MG; Antonescu CR; Van Zee KJ; Brennan MF; Maki RG
Cancer J; 2005; 11(3):241-7. PubMed ID: 16053668
[TBL] [Abstract][Full Text] [Related]
15. [Breast angiosarcoma induced by radiotherapy - surgical treatment options and review of literature].
Kubala O; Prokop J; Petráš L; Ihnát P; Jelínek P; Ostruszka P
Rozhl Chir; 2017; 96(8):353-358. PubMed ID: 29058926
[TBL] [Abstract][Full Text] [Related]
16. Adriamycin, cisplatin, ifosfamide and paclitaxel combination as front-line chemotherapy for locally advanced and metastatic angiosarcoma. Analysis of three case reports and review of the literature.
Asmane I; Litique V; Heymann S; Marcellin L; Métivier AC; Duclos B; Bergerat JP; Kurtz JE
Anticancer Res; 2008; 28(5B):3041-5. PubMed ID: 19031953
[TBL] [Abstract][Full Text] [Related]
17. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
[TBL] [Abstract][Full Text] [Related]
18. Radiation-associated angiosarcoma: diagnostic and therapeutic implications--two case reports and a review of the literature.
Cafiero F; Gipponi M; Peressini A; Queirolo P; Bertoglio S; Comandini D; Percivale P; Sertoli MR; Badellino F
Cancer; 1996 Jun; 77(12):2496-502. PubMed ID: 8640698
[TBL] [Abstract][Full Text] [Related]
19. A Korean single-center, real-world, retrospective study of first-line weekly paclitaxel in patients with metastatic angiosarcoma.
Byeon S; Song HN; Kim HK; Ham JS; Lee SJ; Lee J; Park SH
Clin Sarcoma Res; 2016; 6():8. PubMed ID: 27175275
[TBL] [Abstract][Full Text] [Related]
20. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial.
Formenti SC; Volm M; Skinner KA; Spicer D; Cohen D; Perez E; Bettini AC; Groshen S; Gee C; Florentine B; Press M; Danenberg P; Muggia F
J Clin Oncol; 2003 Mar; 21(5):864-70. PubMed ID: 12610186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
